Isenberg Ventures
Venture capitalMontreal · Seed–Series A · 2 people tracked
Find your way into Isenberg Ventures
Sign up to find every way you can get introduced to Isenberg Ventures
- Your email: who you already know at Isenberg Ventures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Isenberg Ventures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Isenberg Ventures targets a market inefficiency in diagnostics: the gap between proven scientific viability and the difficult path to regulatory approval. The firm treats regulatory complexity as a source of risk-adjusted return, using deep clinical and regulatory expertise to systematically de-risk assets after investment and drive valuation inflection at regulatory milestones. It takes an active operational role, embedding its specialized team into portfolio companies to support clinical validation, regulatory submissions (FDA, CE Mark, Health Canada), and early market access. The strategy emphasizes investing early—when valuations are compressed by regulatory uncertainty—to capture maximum upside as assets move from scientifically validated to commercially approved products.
Source: firm website, verified Oct 2, 2026.
Team · 2 people
from the firm's websiteFrequently asked questions
- What stage does Isenberg Ventures invest at?
- Isenberg Ventures invests at the Seed, Series A stages.
- What sectors does Isenberg Ventures focus on?
- Isenberg Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Isenberg Ventures located?
- Isenberg Ventures is headquartered in Montreal, CA.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.

.jpeg)
